Taiwanese Journal of Obstetrics and Gynecology
Volume 44, Issue 4 , Pages 327-331 , December 2005

New Selective Tissue Estrogenic Activity Regulator (STEAR) in Menopausal Therapy in Taiwan

Received 1 April 2005 ,Revised 4 April 2005 ,Accepted 28 April 2005.

References 

  1. Kloosterboer HJ , Ederveen AGH . Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (± progestogene) treatments . J Steroid Biochem Mol Biol . 2003;83:157–165
  2. Kloosterboer HJ . Tibolone: a steroid with a tissue-specific mode of action . J Steroid Biochem Mol Biol . 2001;76:231–238
  3. Bruce D , Robinson J , McWilliams S , Reddy M , Rymer J . Long-term effects of tibolone on mammographic density . Fertil Steril . 2004;82:1343–1347
  4. Berning B , Bennink HJ , Fauser BC . Tibolone and its effects on bone . Climacteric . 2001;4:120–136
  5. Laan E , van Lunsen RH , Everaerd W . The effects of tibolone on vaginal blood flow, sexual desire and arousability in post-menopausal women . Climacteric . 2001;4:28–41
  6. Nathorst-Boos J , Hammar M . Effect on sexual life-a comparison between tibolone and a continuous estradiolnorethisterone acetate regimen . Maturitas . 1997;26:15–20
  7. Castelo-Branco C , Vicente JJ , Figueras F , et al.   Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women . Maturitas . 2000;34:161–168
  8. Rymer J , Robinson J , Fogelman I . Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women . Climacteric . 2002;5:390–398
  9. Chetrite G , Kloosterboer HJ , Pasqualini JR . Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells . Anticancer Res . 1997;17:135–140
  10. Gompel A , Siromachkova M , Lombet A , Kloosterboer HJ , Rostene W . Tibolone actions on normal and breast cancer cells . Eur J Cancer . 2000;36:S76–S77
  11. Volker W , Coelingh Bennink HJ , Helmond FA . Effects of tibolone on the endometrium . Climacteric . 2001;4:203–208
  12. Kloosterboer HJ , Schoonen WG , Deckers GH , Klijn JG . Effects of progestagens and Org OD14 in in vitro and in vivo tumor models . J Steroid Biochem Mol Biol . 1994;49:311–318
  13. Breast cancer and hormone replacement therapy  . Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer . Lancet . 1997;350:1047–1059
  14. Writing Group for the Women's Health Initiative Investigators  . Risks and benefits of estrogen plus progestin in healthy postmenopausal women . JAMA . 2002;288:321–333
  15. Lundstrom E , Christow A , Kersemaekers W , et al.   Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density . Am J Obstet Gynecol . 2002;186:717–722
  16. Moore RA . Livial: a review of clinical studies . Br J Obstet Gynaecol . 1999;106(Suppl 19):1–21
  17. Gulseren L , Kalafat D , Mandaci H , Gulseren S , Camli L . Effects of tibolone on the quality of life, anxiety-depression levels and cognitive functions in natural menopause: an observational follow-up study . Aust NZ J Obstet Gynaecol . 2005;45:71–73
  18. Landgren MB , Helmond FA , Engelen S . Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day . Maturitas . 2005;50:222–230
  19. Bruce D , Robinson J , Rymer J . Long-term effects of tibolone on the endometrium as assessed by bleeding episodes, transvaginal scan and endometrial biopsy . Climacteric . 2004;7:261–266
  20. Vogelvang TE , van der Mooren MJ , Mijatovic V . Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications . Treat Endocrinol . 2004;3:105–115
  21. Beral V , Million Women Study Collaborators  . Breast cancer and hormone-replacement therapy in the Million Women Study . Lancet . 2003;362:419–427 Lancet . 2003;362:1160; Erratum
  22. Speroff L . The Million Women Study and breast cancer . Maturitas . 2003;46:1–6
  23. Crosignani PG . Breast cancer and hormone-replacement therapy in the Million Women Study . Maturitas . 2003;46:91–92
  24. Bundred NJ , Turner LE . Postmenopausal hormone therapy before and after breast cancer: clinical experiences . Maturitas . 2004;49:S22–S31
  25. Kroiss R , Fentiman IS , Helmond FA , et al.   The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial . BJOG . 2005;112:228–233
  26. Devogelaer JP . A review of the effects of tibolone on the skeleton . Expert Opin Pharmacother . 2004;5:941–949

PII: S1028-4559(09)60165-0

doi: 10.1016/S1028-4559(09)60165-0

Taiwanese Journal of Obstetrics and Gynecology
Volume 44, Issue 4 , Pages 327-331 , December 2005

Article Tools